نتائج البحث - "Caroline Robert"

1

Intratumoural immunotherapies for unresectable and metastatic melanoma: current status and future perspectives

المؤلفون: Christoph Hoeller, Katarina Öhrling, Caroline Robert, Olivier Michielin, Axel Hauschild, Caroline Caramella, Mark R. Middleton

المصدر: British Journal of Cancer

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee068b0d49ba040e0d0087ddfe50259cTest
http://europepmc.org/articles/PMC7492252Test

2

The concepts of rechallenge and retreatment with immune checkpoint blockade in melanoma patients

المؤلفون: Paolo A. Ascierto, Dirk Schadendorf, Selma Ugurel, Alexander M.M. Eggermont, Reinhardt Dummer, Elisabeth Livingstone, Lisa Zimmer, Anne Zaremba, Georgina V. Long, Caroline Robert

المساهمون: University of Zurich, Schadendorf, Dirk

وصف الملف: 906_Zaremba_A._et_al._The_concepts_of_rechallange_and_retreatment_with_immune_checkpoints_blockade_in_melanoma_patients_EJC_2021.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0af59f477caa0569ca2410181854e889Test
https://www.zora.uzh.ch/id/eprint/206131Test/

3

Rationale for Immune Checkpoint Inhibitors plus Targeted Therapy in Metastatic Melanoma : A Review

المؤلفون: Paolo A. Ascierto, Dirk Schadendorf, Reinhard Dummer, Caroline Robert, Paul Nathan

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f1ca59ce0a443693aed8c8e11018ab9Test
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85092193946Test

4

Long-term benefit of adjuvant dabrafenib + trametinib (D+T) in patients (pts) with resected stage III BRAF V600–mutant melanoma : Five-year analysis of COMBI-AD

المؤلفون: Dirk Schadendorf, Caroline Dutriaux, Caroline Robert, Reinhard Dummer, John M. Kirkwood, Marta Nyakas, Mario Mandalà, Laurent Mortier, Axel Hauschild, Kohinoor Dasgupta, Monique Tan, Eduard Gasal, James Larkin, Jacob Schachter, Vanna Chiarion Sileni, Andrew Haydon, Victoria Atkinson, Mario Santinami, Georgina V. Long

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f486f97df79593e3e9abb490624153c0Test

5

The anti–PD-1 antibody spartalizumab in combination with dabrafenib and trametinib in advanced BRAF V600–mutant melanoma : Efficacy and safety findings from parts 1 and 2 of the Phase III COMBI-i trial

المؤلفون: Aisha Masood, Keith T. Flaherty, Reinhard Dummer, Erika Richtig, Hussein Abdul-Hassan Tawbi, Céleste Lebbé, Neha Pakhle, Caroline Robert, Paul Nathan, Naoya Yamazaki, Mario Mandalà, Dirk Schadendorf, Victoria Atkinson, Paolo A. Ascierto, Ana Arance, Antoni Ribas, Georgina V. Long, Eduard Gasal

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c75c8d57ccfac94d27b8372d465da2a0Test

6

Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma

المساهمون: University of Zurich

مصطلحات موضوعية: Male, Oncology, Skin Neoplasms, medicine.medical_treatment, Medizin, Administration, Oral, 2700 General Medicine, 030204 cardiovascular system & hematology, law.invention, 0302 clinical medicine, Randomized controlled trial, law, Antineoplastic Combined Chemotherapy Protocols, Oximes, Medicine, 030212 general & internal medicine, Neoplasm Metastasis, Melanoma, Trametinib, Imidazoles, Follow up studies, 10177 Dermatology Clinic, General Medicine, Middle Aged, Female, Adjuvant, medicine.drug, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, Pyridones, 610 Medicine & health, Pyrimidinones, Disease-Free Survival, 03 medical and health sciences, Adjuvants, Immunologic, Double-Blind Method, Internal medicine, Humans, Stage III melanoma, Protein Kinase Inhibitors, Survival analysis, Aged, Neoplasm Staging, business.industry, Dabrafenib, Survival Analysis, Clinical trial, Mutation, business, Follow-Up Studies

وصف الملف: 848_Dummer_R._et_al._Five-Year_Analysis_of_Adjuvant_Dabrafenib_plus_Trametinib_in_Stage_III_Melanoma_NEJM_2020.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d710d2b0f671e5dafc838391b9965d4aTest
https://www.zora.uzh.ch/id/eprint/190018Test

7

Timing of completion lymphadenectomy after positive sentinel node biopsy in patients with melanoma

المؤلفون: P. Siegel, C. M. C. Oude Ophuis, Piotr Rutkowski, A.C.J. van Akkooi, Alessandro Testori, B.L. van Leeuwen, Caroline Robert, Alexander M.M. Eggermont, Cees Verhoef, Dirk J. Grünhagen, W. E. M. Powell

المساهمون: Damage and Repair in Cancer Development and Cancer Treatment (DARE), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Clinical Cognitive Neuropsychiatry Research Program (CCNP), Surgery

المصدر: British Journal of Surgery, 104(6), 726-733. Wiley
British Journal of Surgery, 104(6), 726-733. John Wiley & Sons Ltd.

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Skin Neoplasms, PROGNOSIS, CUTANEOUS MELANOMA, medicine.medical_treatment, Sentinel lymph node, MULTICENTER, 030230 surgery, Disease-Free Survival, Time-to-Treatment, 03 medical and health sciences, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Biopsy, medicine, Humans, RECURRENCE, Lymph node, Melanoma, DISSECTION, Retrospective Studies, medicine.diagnostic_test, business.industry, Proportional hazards model, Sentinel Lymph Node Biopsy, Retrospective cohort study, Sentinel node, Middle Aged, medicine.disease, Surgery, Tumor Burden, TIME, medicine.anatomical_structure, Treatment Outcome, 030220 oncology & carcinogenesis, Lymphatic Metastasis, SURVIVAL, Lymph Node Excision, UPDATE, Lymphadenectomy, Female, TRIAL, Radiology, Sentinel Lymph Node, business